
Invitae Investor Relations Material
Latest events

Q3 2023
Invitae
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Invitae Corporation
Access all reports
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people. The company offers clinical and genetic testing services to evaluate the risk of inherited conditions. It also provides diagnostic products and services, including laboratory developed tests and other diagnostic reagents to physicians and hospitals. The company offers hereditary cancer testing services under the Vectra 360 brand, prenatal testing services under the Angelica brand, and germline gene mutation screening under the Genomind brand. The company is based in San Francisco, California.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NVTA
Country
🇺🇸 United States